Cargando…
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137010/ https://www.ncbi.nlm.nih.gov/pubmed/37189487 http://dx.doi.org/10.3390/diagnostics13081386 |
_version_ | 1785032356131766272 |
---|---|
author | Alenazi, Aqeel M. Alhowimel, Ahmed S. Alshehri, Mohammed M. Alqahtani, Bader A. Alhwoaimel, Norah A. Segal, Neil A. Kluding, Patricia M. |
author_facet | Alenazi, Aqeel M. Alhowimel, Ahmed S. Alshehri, Mohammed M. Alqahtani, Bader A. Alhwoaimel, Norah A. Segal, Neil A. Kluding, Patricia M. |
author_sort | Alenazi, Aqeel M. |
collection | PubMed |
description | Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA. |
format | Online Article Text |
id | pubmed-10137010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101370102023-04-28 Osteoarthritis and Diabetes: Where Are We and Where Should We Go? Alenazi, Aqeel M. Alhowimel, Ahmed S. Alshehri, Mohammed M. Alqahtani, Bader A. Alhwoaimel, Norah A. Segal, Neil A. Kluding, Patricia M. Diagnostics (Basel) Review Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA. MDPI 2023-04-10 /pmc/articles/PMC10137010/ /pubmed/37189487 http://dx.doi.org/10.3390/diagnostics13081386 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Alenazi, Aqeel M. Alhowimel, Ahmed S. Alshehri, Mohammed M. Alqahtani, Bader A. Alhwoaimel, Norah A. Segal, Neil A. Kluding, Patricia M. Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title | Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title_full | Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title_fullStr | Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title_full_unstemmed | Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title_short | Osteoarthritis and Diabetes: Where Are We and Where Should We Go? |
title_sort | osteoarthritis and diabetes: where are we and where should we go? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137010/ https://www.ncbi.nlm.nih.gov/pubmed/37189487 http://dx.doi.org/10.3390/diagnostics13081386 |
work_keys_str_mv | AT alenaziaqeelm osteoarthritisanddiabeteswhereareweandwhereshouldwego AT alhowimelahmeds osteoarthritisanddiabeteswhereareweandwhereshouldwego AT alshehrimohammedm osteoarthritisanddiabeteswhereareweandwhereshouldwego AT alqahtanibadera osteoarthritisanddiabeteswhereareweandwhereshouldwego AT alhwoaimelnoraha osteoarthritisanddiabeteswhereareweandwhereshouldwego AT segalneila osteoarthritisanddiabeteswhereareweandwhereshouldwego AT kludingpatriciam osteoarthritisanddiabeteswhereareweandwhereshouldwego |